Niagen Bioscience, Inc. — Director's Dealing 2011

Nov 25, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ChromaDex Corp. (CDXC.OB)
CIK: 0001386570
Period of Report: 2011-11-22

Reporting Person: FROST PHILLIP MD ET AL (N/A)
Reporting Person: Frost Gamma Investments Trust (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-11-22	Common Stock	S	5400	$0.88	Disposed	14319604	Indirect

Footnotes

F1: Securities held by Frost Gamma Investments Trust of which the Reporting Person is the Trustee and Frost Gamma Limited Partnership ("FGLP") is the sole and exclusive beneficiary. The Reporting Person is one of two limited partners of FGLP. The general partner of FGLP is Frost Gamma Inc. ("FGI"), and the sole shareholder of FGI is Frost-Nevada Corporation ("FNC"). The Reporting Person is also the sole shareholder of FNC.